Raschi E.; De Ponti F., Strategies for early prediction and timely recognition of drug-induced liver injury: The case of cyclin-dependent kinase 4/6 inhibitors, «FRONTIERS IN PHARMACOLOGY», 2019, 10, Article number: 1235 , pp. 1 - 15 [Scientific article]Open Access
Raschi, E.; Mazzarella, A.; Antonazzo, I. C.; Bendinelli, N.; Forcesi, E.; Tuccori, M.; Moretti, U.; Poluzzi, E.; De Ponti, F., Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System, «TARGETED ONCOLOGY», 2019, 14, pp. 205 - 221 [Scientific article]Open Access
Dothel, Giovanni; Barbaro, Maria Raffaella; Raschi, Emanuel; Barbara, Giovanni; De Ponti, Fabrizio*, Advancements in drug development for diarrhea-predominant irritable bowel syndrome, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2018, 27, pp. 251 - 263 [Scientific article]
Raschi, Emanuel*; Girardi, Anna; Poluzzi, Elisabetta; Forcesi, Emanuele; Menniti-Ippolito, Francesca; Mazzanti, Gabriela; De Ponti, Fabrizio, Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems, «DRUG SAFETY», 2018, 41, pp. 745 - 752 [Scientific article]
Raschi, Emanuel; Diemberger, Igor; Cosmi, Benilde; De Ponti, Fabrizio, ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations, «INTERNAL AND EMERGENCY MEDICINE», 2018, 13, pp. 1 - 9 [Scientific article]
Raschi E.; Diemberger I.; Cosmi B.; De Ponti F., ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations—authors’ reply, «INTERNAL AND EMERGENCY MEDICINE», 2018, 13, pp. 635 - 636 [Comment or similar]
Barbaro, M.R.; Fuschi, D.; Cremon, C.; Carapelle, M.; Dino, P.; Marcellini, M.M.; Dothel, G.; De Ponti, F.; Stanghellini, V.; Barbara, G.*, Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators, «NEUROGASTROENTEROLOGY AND MOTILITY», 2018, 30, Article number: e13388 , pp. e13388 - 10 [Scientific article]
Maselli, Maria Antonietta*; Ignazzi, Antonia; Pezzolla, Francesco; Scirocco, Annunziata; Lorusso, Dionigi; De Ponti, Fabrizio; Severi, Carola, Gender-differences of in vitro colonic motility after chemo- and radiotherapy in humans, «BMC PHARMACOLOGY & TOXICOLOGY», 2018, 19, Article number: 49 , pp. 1 - 8 [Scientific article]Open Access
Mouchet, Julie; Salvo, Francesco; Raschi, Emanuel; Poluzzi, Elisabetta; Antonazzo, Ippazio Cosimo; De Ponti, Fabrizio; Bégaud, Bernard, Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis, «VACCINE», 2018, 36, pp. 1548 - 1555 [Scientific article]
Mouchet, Julie; Salvo, Francesco; Raschi, Emanuel; Poluzzi, Elisabetta; Antonazzo, Ippazio Cosimo; De Ponti, Fabrizio; Bégaud, Bernard, Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis, «PHARMACOLOGICAL RESEARCH», 2018, 132, pp. 108 - 118 [Scientific article]
Antonazzo, Ippazio Cosimo; Raschi, Emanuel; Forcesi, Emanuele; Riise, Trond; Bjornevik, Kjetil; Baldin, Elisa; De Ponti, Fabrizio; Poluzzi, Elisabetta, Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System, «EXPERT OPINION ON DRUG SAFETY», 2018, 17, pp. 869 - 874 [Scientific article]
Mei, Riccardo; Raschi, Emanuel; Forcesi, Emanuele; Diemberger, Igor; De Ponti, Fabrizio; Poluzzi, Elisabetta, Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System, «INTERNATIONAL JOURNAL OF CARDIOLOGY», 2018, 273, pp. 183 - 186 [Scientific article]
Carnovale, Carla; Raschi, Emanuel; Leonardi, Luca; Moretti, Ugo; De Ponti, Fabrizio; Gentili, Marta; Pozzi, Marco; Clementi, Emilio; Poluzzi, Elisabetta; Radice, Sonia, No signal of interactions between influenza vaccines and drugs used for chronic diseases: a case-by-case analysis of the vaccine adverse event reporting system and vigibase, «EXPERT REVIEW OF VACCINES», 2018, 17, pp. 363 - 381 [Scientific article]
Raschi, Emanuel*; Poluzzi, Elisabetta; Fadini, Gian Paolo; Marchesini, Giulio; De Ponti, Fabrizio, Observational research on sodium glucose co-transporter-2 inhibitors: A real breakthrough?, «DIABETES, OBESITY AND METABOLISM», 2018, 20, pp. 2711 - 2723 [Scientific article]Open Access
Raschi, Emanuel; Mazzotti, Arianna; Poluzzi, Elisabetta; De Ponti, Fabrizio; Marchesini, Giulio*, Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease, «EXPERT OPINION ON PHARMACOTHERAPY», 2018, 19, pp. 1903 - 1914 [Scientific article]
